Vitamin D in European children-statement from the European Academy of Paediatrics (EAP).
Study Goal
The researchers aimed to evaluate the role of vitamin D in calcium and phosphate metabolism and its importance for bone health, particularly in preventing rickets and addressing deficiency in high-risk groups.
Results Summary
The study affirmed that vitamin D is essential for bone health and preventing rickets, with supplementation recommended for infants up to 1 year (400 IU/day). However, routine screening for deficiency in healthy children is unjustified due to unclear definitions of deficiency and inter-assay variability.
Population
Healthy and high-risk children (e.g., darker pigmented skin, reduced sun exposure areas, and other disorders), particularly infants up to 1 year.
Effective Dosage
400 IU/day (oral supplementation for infants up to 1 year).
Duration
Not specified beyond infancy (up to 1 year).
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Vitamin D supplementation | neutral | bone health | - | - | is essential for the maintenance of | #1 |
Vitamin D supplementation | decrease | rickets | infants | - | is universally accepted to prevent | #2 |
oral supplementation of 400 IU/day of vitamin D | neutral | - | All infants up to 1 year of age | 400 IU/day | should be received by | #3 |
Vitamin D is synthesized in human skin upon sun exposure and is also a nutrient. It regulates calcium and phosphate metabolism and is essential for the maintenance of bone health. Vitamin D supplementation during infancy, in order to prevent rickets, is universally accepted. Many human cell types carry vitamin D receptor, this being a drive for conducting studies on the possible association between vitamin D status and other diseases. Studies have affirmed that a considerable number of healthy European children may be vitamin D deficient, especially in high-risk groups (darker pigmented skin, living in areas with reduced sun exposure and other disorders). However, the definition of deficiency is unclear due to inter assay differences and due to a lack of consensus as to what is an "adequate" 25(OH)D level. Therefore, there is no justification for routine screening for vitamin D deficiency in healthy children. An evaluation of vitamin D status is justified in children belonging to high-risk groups. All infants up to 1 year of age should receive an oral supplementation of 400 IU/day of vitamin D. Beyond this age, seasonal variation of sunlight should be taken into account when considering a national policy of supplementation or fortification.